Metabolic syndrome contributes to cognitive impairment in patients with Parkinson's disease

Metabolic syndrome (MetS) increases the risk of cognitive impairment in normal aging but this has not been studied in Parkinson's Disease (PD). The purpose of this study was to investigate the impact of MetS on cognitive impairment in PD.

Source: Parkinsonism and Related Disorders - May 17, 2018 Category: Neurology Authors: Zeyan Peng, Shuyang Dong, Yong Tao, Yingchao Huo, Zhenhua Zhou, Wen Huang, Hongdang Qu, Juan Liu, Yang Chen, Zhiqiang Xu, Yanjiang Wang, Huadong Zhou Source Type: research